Thu, 19 Sep 2013 18:19:04 GMT
Roche will buy BioMarin without raising extra money
Roche Holding AG, a Swiss based health care company, plans to acquire a California-based BioMarin Pharmaceutical Inc., a company, which produces and develops drugs for treating rare diseases and cancer. A possible cost of the deal can reach $15 billion, and Roche will not borrow extra money to pay for BioMarin. On Thursday Roche Holding AG stocks add 0.03% to